| Title: | Wyeth at Morgan Stanley 2008 Global Healthcare Unplugged Conference Transcript |
| Price: | $54.00 |
| Publication Date: | Apr 30, 2008 |
| Source: | Thomson StreetEvents |
| Report Type: | Transcript |
| Abstract: | Final Transcript of WYE presentation, 30-Apr-08 10:30am ET |
| Brief Excerpt: | ...Okay. Thank you, everybody, for joining us today in what I think should be a really interesting session with the management of Wyeth.Today, we have Jim Connolly, who is head of the Vaccine Division of Wyeth, and Justin Victoria, who heads up Investor Relations. Clara [Ball] is also in the audience. But, I think the next ## minutes should be quite interesting. Jim, I thought maybe if you could just start -- respond to this question. Vaccines, in my opinion, have been one of the real gems of the Wyeth story. And you guys really put the blockbuster vaccine on the books with Prevnar. It's been a sensational success story. And my question for you is how does Wyeth further monetize this important asset, and where do you see Wyeth's place in the future in vaccines? And maybe you could talk about vaccines in the context of biopharmaceuticals and --. ... |
| Word Count: | 8438 |
| Length: | 16 Pages |
| Ticker: | WYE |
| Time: | 10:30am ET |
| Related Report(s): | |
| Format: | 
Adobe Acrobat
|
| Free Sample: |
Click
Here
to Download
|
Looking For Something Else?
